Announcements Trials
Browse Landscape

Phase

Phase 2 230Phase 3 126Phase NA 69Phase 1 38Phase 1/2 33Phase 2/3 10Phase EARLY_PHASE1 7Phase 4 4

Status

Unknown 3Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Head & Neck 4

Conditions

Breast Neoplasms 276Neoplasms 202Prostatic Neoplasms 118Polycystic Ovary Syndrome 114Colorectal Neoplasms 103Carcinoma, Hepatocellular 103Carcinoma, Non-Small-Cell Lung 88Lung Neoplasms 70Stomach Neoplasms 62Precursor Cell Lymphoblastic Leukemia-Lymphoma 60Pain 59Neoplasm Metastasis 54Multiple Myeloma 52Pancreatic Neoplasms 46Keratosis, Actinic 46Head and Neck Neoplasms 43Pain, Postoperative 42Leukemia, Myeloid, Acute 40Leiomyoma 39Recurrence 38Liver Neoplasms 38Colonic Neoplasms 37Uterine Cervical Neoplasms 35Lymphoma 35Brain Neoplasms 34Infertility 33Papillomavirus Infections 32Ovarian Neoplasms 31Lymphoma, Follicular 31Lymphoma, Non-Hodgkin 30

Interventions

nimotuzumab 1Radiosurgery 1Morphine 1Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Nasopharyngeal Carcinoma × Clear all
NCT04292990 2020-07-29

Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients

Jiangmen Central Hospital

Phase 4 Unknown
300 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Pain

NCT01344356 2020-04-10

Stereotactic Body Radiotherapy for Head and Neck Tumors

Mercy Research

Phase 4 Completed
19 enrolled 10 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT02948699 2018-12-04

A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients

Zhejiang Cancer Hospital

Phase 4 Unknown
114 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

NCT02293356 2015-08-19

Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma

Biotech Pharmaceutical Co., Ltd.

Phase 4 Unknown
2,000 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡